191 related articles for article (PubMed ID: 7629299)
1. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukaemia cells.
Mainou-Fowler T; Copplestone JA; Prentice AG
J Clin Pathol; 1995 May; 48(5):482-7. PubMed ID: 7629299
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia.
Reittie JE; Yong KL; Panayiotidis P; Hoffbrand AV
Leuk Lymphoma; 1996 Jun; 22(1-2):83-90, follow. 186, color plate VI. PubMed ID: 8724532
[TBL] [Abstract][Full Text] [Related]
3. Release of interleukin-6 in cultured B-chronic lymphocytic leukaemia cells is associated with both activation and cell death via apoptosis.
Büssing A; Stein GM; Stumpf C; Schietzel M
Anticancer Res; 1999; 19(5B):3953-9. PubMed ID: 10628337
[TBL] [Abstract][Full Text] [Related]
4. Abnormal response to IL-5 in B-cell chronic lymphocytic leukemia.
Hayes TG; Tan XL; Moseley AB; Huston MM; Huston DP
Leuk Res; 1993 Sep; 17(9):777-83. PubMed ID: 8371578
[TBL] [Abstract][Full Text] [Related]
5. Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells.
Zinzani PL; Buzzi M; Farabegoli P; Tosi P; Fortuna A; Visani G; Martinelli G; Zaccaria A; Tura S
Leuk Lymphoma; 1994 Mar; 13(1-2):95-7. PubMed ID: 8025527
[TBL] [Abstract][Full Text] [Related]
6. Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukaemia.
Mainou-Fowler T; Prentice AG
Leuk Lymphoma; 1996 May; 21(5-6):369-77. PubMed ID: 9172801
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B cells from in vitro apoptosis.
Chaouchi N; Wallon C; Goujard C; Tertian G; Rudent A; Caput D; Ferrera P; Minty A; Vazquez A; Delfraissy JF
Blood; 1996 Feb; 87(3):1022-9. PubMed ID: 8562926
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro.
Panayiotidis P; Ganeshaguru K; Jabbar SA; Hoffbrand AV
Br J Haematol; 1993 Nov; 85(3):439-45. PubMed ID: 8136263
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells.
Reittie JE; Hoffbrand AV
Leuk Res; 1994 Jan; 18(1):55-60. PubMed ID: 8289467
[TBL] [Abstract][Full Text] [Related]
10. The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathways.
de Totero D; Meazza R; Capaia M; Fabbi M; Azzarone B; Balleari E; Gobbi M; Cutrona G; Ferrarini M; Ferrini S
Blood; 2008 Jan; 111(2):517-24. PubMed ID: 17938255
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 and a T cell hybridoma (MP6) derived B cell-stimulatory factor act synergistically to induce proliferation and differentiation of human B-chronic lymphocytic leukemia cells.
Carlsson M; Tötterman TH; Rosén A; Nilsson K
Leukemia; 1989 Aug; 3(8):593-601. PubMed ID: 2787454
[TBL] [Abstract][Full Text] [Related]
12. IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.
Sainz-Perez A; Gary-Gouy H; Gaudin F; Maarof G; Marfaing-Koka A; de Revel T; Dalloul A
J Immunol; 2008 Nov; 181(9):6051-60. PubMed ID: 18941194
[TBL] [Abstract][Full Text] [Related]
13. High Mda-7 expression promotes malignant cell survival and p38 MAP kinase activation in chronic lymphocytic leukemia.
Sainz-Perez A; Gary-Gouy H; Portier A; Davi F; Merle-Beral H; Galanaud P; Dalloul A
Leukemia; 2006 Mar; 20(3):498-504. PubMed ID: 16408101
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the mechanism underlying antitumor effect of interleukin 27 on B cells of chronic lymphocytic leukemia patients.
Manouchehri-Doulabi E; Abbaspour S; Rostami S; Faranoush M; Ghahramanfard F; Pak F; Barati M; Kokhaei P; Momtazi-Borojeni AA
J Cell Physiol; 2020 Dec; 235(12):9424-9431. PubMed ID: 32383245
[TBL] [Abstract][Full Text] [Related]
15. Modulation of IL-4 level by fludarabine and its relation to apoptosis in chronic B-cell lymphocytic leukemia.
Shamaa LA; Hussein Ael-S; Balbaa OA; Farahat NM; Ali MA
Egypt J Immunol; 2008; 15(1):181-92. PubMed ID: 20306682
[TBL] [Abstract][Full Text] [Related]
16. Antiapoptotic effect of interleukin-2 (IL-2) in B-CLL cells with low and high affinity IL-2 receptors.
Decker T; Bogner C; Oelsner M; Peschel C; Ringshausen I
Ann Hematol; 2010 Nov; 89(11):1125-32. PubMed ID: 20544350
[TBL] [Abstract][Full Text] [Related]
17. Proliferation of B cells from chronic lymphocytic leukemia is selectively promoted by B cell growth factor.
Alvarez-Mon M; de la Hera A; Gaspar ML; Orfao A; Casas J; Jordá J; Durantez A
Acta Haematol; 1989; 81(2):91-7. PubMed ID: 2496557
[TBL] [Abstract][Full Text] [Related]
18. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta.
Douglas RS; Capocasale RJ; Lamb RJ; Nowell PC; Moore JS
Blood; 1997 Feb; 89(3):941-7. PubMed ID: 9028325
[TBL] [Abstract][Full Text] [Related]
19. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia.
Castejón R; Vargas JA; Romero Y; Briz M; Muñoz RM; Durántez A
Cytometry; 1999 Oct; 38(5):224-30. PubMed ID: 10516608
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-5 (IL-5) increases spontaneous apoptosis of B-cell chronic lymphocytic leukemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4.
Mainou-Fowler T; Craig VA; Copplestone JA; Hamon MD; Prentice AG
Blood; 1994 Oct; 84(7):2297-304. PubMed ID: 7919349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
